Identification of a Novel Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase: In Vitro and In Silico Studies (original) (raw)
Synthesis, pharmacological assessment, and molecular modeling of acetylcholinesterase/butyrylcholinesterase inhibitors: effect against amyloid-β-induced neurotoxicity
Abdelouahid Samadi
ACS chemical neuroscience, 4, 547−565, 2013, 2013
View PDFchevron_right
Combined QSAR, molecular docking and molecular dynamics study on new Acetylcholinesterase and Butyrylcholinesterase inhibitors
Ismail Ait daoud
Computational biology and chemistry, 2018
View PDFchevron_right
Synthesis, Pharmacological Assessment, and Molecular Modeling of Acetylcholinesterase/Butyrylcholinesterase Inhibitors: Effect against Amyloid-beta-Induced Neurotoxicity
Daniel Silva, Eduarda Mendes
View PDFchevron_right
New cholinesterase inhibitors for Alzheimer’s disease: Structure Activity Studies (SARs) and molecular docking of isoquinolone and azepanone derivatives
Cátia Guarda
Bioorganic Chemistry, 2016
View PDFchevron_right
Docking, dynamic simulation and quantum mechanics studies of pyrazinamide derivatives as novel inhibitors of Acetylcholinesterase and Butyrylcholinesterase
said Ghalem
2015
View PDFchevron_right
Integrated 3D-QSAR, molecular docking, and molecular dynamics simulation studies on 1,2,3-triazole based derivatives for designing new acetylcholinesterase inhibitors
ATUL KUMAR SINGH
View PDFchevron_right
Novel hits for acetylcholinesterase inhibition derived by docking-based screening on ZINC database
Iva Valkova
Journal of enzyme inhibition and medicinal chemistry, 2018
View PDFchevron_right
Potential acetylcholinesterase inhibitors: molecular docking, molecular dynamics, and in silico prediction
Ricardo Gargano
Journal of molecular modeling, 2017
View PDFchevron_right
Molecular interactions of cholinesterases inhibitors using in silico methods: current status and future prospects
Hassan Khan
New Biotechnology, 2009
View PDFchevron_right
Dual Binding Site and Selective Acetylcholinesterase Inhibitors Derived from Integrated Pharmacophore Models and Sequential Virtual Screening
C Gopi Mohan
BioMed Research International, 2014
View PDFchevron_right
Design and development of novel p-aminobenzoic acid derivatives as potential cholinesterase inhibitors for the treatment of Alzheimer's disease
Lalit M Aggarwal
Bioorganic chemistry, 2018
View PDFchevron_right
The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity
Marko Zivin
Journal of medicinal chemistry, 2018
View PDFchevron_right
1H-benzimidazole derivatives as butyrylcholinesterase inhibitors: synthesis and molecular modeling studies
sulunay parlar
Medicinal Chemistry Research, 2016
View PDFchevron_right
Benzene-1,3-diol derivatives as the inhibitors of butyrylcholinesterase: An emergent target of Alzheimer's disease
Journal of the Serbian Chemical Society
Journal of the Serbian Chemical Society, 2022
View PDFchevron_right
Structural Dynamics and Susceptibility of Anti-Alzheimer’s Drugs Donepezil and Galantamine against Human Acetylcholinesterase
Somchai Yanarojana
Trends in Sciences
View PDFchevron_right
Discovery of Novel Acetylcholinesterase Inhibitor Implication for the Design of New Anti-Alzheimer Agents
Amir Zeb
View PDFchevron_right
Kinetics and computational study of butyrylcholinesterase inhibition by methylrosmarinate: relevance to Alzheimer’s disease treatment
miriam watafua
Heliyon
View PDFchevron_right
Computational Investigation of the Interaction Mechanism of Some anti-Alzheimer Drugs with the Acetylcholinesterase Enzyme
ali osman coşgun
2023
View PDFchevron_right
Development of an in-vivo active reversible butyrylcholinesterase inhibitor
Marko Zivin
Scientific Reports, 2016
View PDFchevron_right
The Discovery of Potential Acetyl Cholinesterase Inhibitors: A Combination of Virtual Screening and Molecular Docking Studies
International Journal of Trend in Scientific Research and Development - IJTSRD, Anjali Tripathi
View PDFchevron_right
Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, an experimental Alzheimer's drug candidate: validation of enzoinformatics results by classical and innovative enzyme kinetic analyses
Nigel Greig
CNS & neurological disorders drug targets, 2017
View PDFchevron_right
Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer’s Disease
Amir Zeb
International Journal of Molecular Sciences
View PDFchevron_right
Virtual Screening of Acetylcholinesterase Inhibitors Using the Lipinski’s Rule of Five and ZINC Databank
Pablo Nogara, Lílian Lissner, Diones Bueno, Cristiane L Dalla Corte, João Rocha
BioMed Research International, 2015
View PDFchevron_right
Targeting acetylcholinesterase: identification of chemical leads by high throughput screening, structure determination and molecular modeling
Anna Linusson
PloS one, 2011
View PDFchevron_right
Novel Hybrid Molecules of Cholinesterase Inhibitor for Alzheimer’s Disease: A Systematic Review
DR NURUL ZAWANI ALIAS
2017
View PDFchevron_right